Table 3.

Adjusted 3-year survival by chronic kidney disease and coronary artery disease treatment group

CAD Group	1 VD	2 VD	3 VD	LMD
Normal–mild CKD
PCI vs. medical (years)
PCI	2.898	2.840	2.713	–
Medical	2.841	2.782	2.551	–
Difference	0.057	0.058	0.162	–
90% CI	0.004; 0.109	−0.018; 0.138	0.014; 0.308	–
PCI life-saving (%)	96.8	88.9	97.0	–
CABG vs. medical (years)
CABG	–	2.806	2.818	2.845
Medical	–	2.768	2.489	2.246
Difference	–	0.038	0.329	0.599
90% CI	–	−0.065; 0.137	0.212; 0.458	0.191; 1.120
CABG life-saving (%)	–	73.3	100.0	99.6
CABG vs. PCI (years)
CABG	–	2.802	2.825	–
PCI	–	2.852	2.727	–
Difference	–	−0.050	0.098	–
90% CI	–	−0.136; 0.034	−0.030; 0.232	–
CABG life-saving (%)	–	17.1	89.6	–
Moderate-severe CKD
PCI vs. medical (years)
PCI	2.643	2.555	2.170	–
Medical	2.583	2.488	2.167	–
Difference	0.060	0.067	0.003	–
90% CI	−0.127; 0.234	−0.108; 0.261	−0.331; 0.350	–
PCI life-saving (%)	69.4	73.5	54.3	–
CABG vs. medical (years)
CABG	–	2.786	2.540	2.610
Medical	–	2.426	2.266	1.881
Difference	–	0.360	0.274	0.729
90% CI	–	0.162; 0.571	0.084; 0.514	0.302; 1.182
CABG life-saving (%)	–	99.7	99.0	99.9
CABG vs. PCI (years)
CABG	–	2.834	2.569	–
PCI	–	2.583	2.162	–
Difference	–	0.251	0.407	–
90% CI	–	0.077; 0.407	0.057; 0.780	–
CABG life-saving (%)	–	98.8	97.3	–

CAD Coronary artery disease, VD ventricular disease, LMD left main disease, CKD chronic kidney disease